Nav: Home

Sizing up tumor DNA fragments improves blood-based cancer detection

November 07, 2018

Florent Mouliere and colleagues have designed a new method that was able to detect hard-to-trace tumor DNA in the blood (or ctDNA). Their technique could outperform the cancer-sniffing capabilities of existing methods by accounting for differences in the size of ctDNA fragments, rather than genomic changes in ctDNA. The blood plasma of cancer patients contains DNA that originates from primary or secondary tumors, and researchers have suspected that zeroing in on ctDNA may offer a safe and noninvasive alternative compared to conventional biopsies - requiring only a small blood sample. However, ctDNA is difficult to identify because it is typically outnumbered by much larger quantities of noncancerous DNA that also circulates in the blood. Previous research has shown that fragments of circulating DNA from fetuses can be distinguished from maternal DNA because of their shorter lengths, a finding that helped to improve the sensitivity of prenatal diagnosis. Taking inspiration from this discovery, Mouliere et al. used whole-genome sequencing to survey the sizes of ctDNA fragments in 344 plasma samples from 200 cancer patients. They identified biological features that were enriched in ctDNA associated with each patient's cancer type, and developed computational methods to select for specific ctDNA fragment sizes. The authors found that focusing on fragments between 90 and 150 base pairs long - the unit of measurement for genetic material - improved detection of ctDNA from patients with brain, renal and pancreatic cancer. The authors say that size selection could have an impact on the detection of other types of DNA (such as mitochondrial DNA) in body fluids. A related Focus by Ellen Heitzer and Michael. R. Speicher describes the study in more detail.

American Association for the Advancement of Science

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...